UHS joins forces with Hippocrates IA to launch AI agents

Diving brief:

• Universal Health Services and Hippocratic IA publish an AI agent to help clinicians make phone follow -up to patients after the discharge, companies said in a press release on Monday.
• Companies hope that generative AI agents Will better help clinicians monitor patients’ well-being after leaving the hospital by quickly detecting changes in their conditions and questions on the ground.
• The UHS launched the program in two subsidiaries earlier this year, but plans to extend the pilot after receiving positive comments from patients, the statement said.

Diving insight:

While beating media continues to grow around AI, health systems is increasingly piloting solutions, such as Hippocrates’s origin of original AI, in the hope that technology will help them to rationalize the tasks of clinicians and reduce professional exhaustion.

The agentic AI, which can act independently to make decisions with little human surveillance, is becoming more and more popular in health care, with technological and notable companies, Google Cloud and Salesforce offering all agent tools which, according to them, can reduce the administrative burden for workers.

Hippocrates’ tool acts as a first point of contact for patients after discharge. The company said that the tool calls on patients to examine medication instructions, probe signs of new symptoms or aggravation and answer patient questions.

Patients also have the possibility of connecting with a human nurse: UHS said that clinicians can recall patients after the initial AI call.

UHS launched AI agents for the first time in its Summerlin hospital medical center based in Las Vegas and Texoma Medical Center, based in Texas. The health system said that patients have given the tool an average note of 9 out of 10.

The health system plans to deploy technology to more than 10 additional American hospitals in the coming months due to positive reception, a spokesperson said. Following this, UHS plans to launch technology in all its 29 active care hospitals.

“We were very happy to see the patient’s reaction in the overall commitment to the Genai agent. To date, we have experienced a high degree of success, and we are impatient to continue to extend the size of the sample “,” said Uhs The president and chief executive officer Marc Miller.

UHS said agents should allow nurses to be more effective. However, some experts have expressed their concern that health systems cannot take AI time savings to clinicians as expected.